Press release
Hereditary Testing Market to Reach USD 17.13 billion by 2034, Driven by 8.3% CAGR Growth
Hereditary Testing Market
The hereditary testing market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyzes the market to account for USD 17.13 billion by 2034 and is expected to register a CAGR of 8.3% in the above-mentioned forecast period. The market was valued at USD 7.73 billion in 2024.
Market Analysis
Hereditary testing includes inspecting the DNA, the chemical database that conveys directives from the body's operations. Hereditary testing can disclose alterations in the genes that may cause illness or disease. Albeit hereditary testing can offer crucial details for detecting, curing, and prohibiting illness, there are restrictions. For instance, if a person is healthy, an affirmative outcome for hereditary testing cannot always indicate that one will advance an illness.
Hereditary testing plays an important part in assessing the probability of advancing specific illnesses as well as screening and often medical cures. If one has indications of illness that may be developed by genetic alterations often known as mutated genes. Genetic testing can divulge if individuals have a surmising illness. For instance, genetic testing might be utilized to substantiate a diagnosis of cystic fibrosis or Huntington's disease.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market/request-for-sample
Driving Factors
Technological Progressions
The market has encountered notable growth due to the speedy progression in genetic testing technologies. Inventions such as next-generation sequencing (NGS) have enhanced the preciseness, speed, and cost-effectiveness of genetic analysis, making hereditary testing more approachable. These technological enhancements have eased the discovery of a wider gamut of genetic mutations, thereby augmenting the scope of genetic testing applications supporting the hereditary testing market expansion.
Growing Awareness of Personalized Medicines
There is a growing identification of advantages of personalized medicine which customizes healthcare dependent on personal genetic profiles. This consciousness has caused accelerated approval and demand for hereditary testing as persons and healthcare donors look to comprehend genetic tendencies to several conditions.
Competitive Landscape
The competitive landscape of the market is portrayed by fierce contention amidst key contenders striving to invent and augment their market existence. Some of the prominent players operating in the market include:
• CENTOGENE N.V.
• F. Hoffmann-La Roche Ltd.
• Fulgent Genetics, Inc.
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• MedGenome Inc.
• Myriad Genetics, Inc.
• Natera, Inc.
• Quest Diagnostics Incorporated
• SOPHiA GENETICS SA
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation
• WuXi NextCODE Genomics, Inc
Inquire more about this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market/inquire-before-buying
Segmentation Analysis
The hereditary testing market segmentation is based on technology, sample type, disease type, and region.
Based on technology, the molecular testing segment held the largest market share in 2024 credited to the extensive acquisition of molecular methodologies such as next-generation sequencing and polymerase chain reaction.
Based on sample type, the blood segment dominated the market in 2024 due to the dependability and effortlessness of comfort of collection linked with blood samples that offer an abundant source of DNA important for precise genetic analysis.
Hereditary Testing Market, Technology Outlook (Revenue - USD Billion, 2020-2034)
• Cytogenetic
• Biochemical
• Molecular Testing
Hereditary Testing Market, Sample Type Outlook (Revenue - USD Billion, 2020-2034)
• Tumor Tissue
• Bone Marrow
• Saliva
• Blood
• Others
Hereditary Testing Market, Disease Type Outlook (Revenue - USD Billion, 2020-2034)
• Hereditary Cancer
• Lung Cancer
• Colorectal Cancer
• Ovarian Cancer
• Prostate Cancer
• Breast Cancer
• Melanoma
• Sarcoma
• Others
Explore The Complete Report:
https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market
Geographical Insights
Hereditary Testing Market, Regional Outlook (Revenue - USD Billion, 2020-2034)
🔹 North America
» Technology Outlook
» Cytogenetic
» Biochemical
» Molecular Testing
» Sample Type Outlook
» Tumor Tissue
» Bone Marrow
» Saliva
» Blood
» Others
» Disease Type Outlook
» Hereditary Cancer
» Lung Cancer
» Colorectal Cancer
» Ovarian Cancer
» Prostate Cancer
» Breast Cancer
» Melanoma
» Sarcoma
» Others
🔹 Europe
» Technology Outlook
» Cytogenetic
» Biochemical
» Molecular Testing
» Sample Type Outlook
» Tumor Tissue
» Bone Marrow
» Saliva
» Blood
» Others
» Disease Type Outlook
» Hereditary Cancer
» Lung Cancer
» Colorectal Cancer
» Ovarian Cancer
» Prostate Cancer
» Breast Cancer
» Melanoma
» Sarcoma
» Others
✅ FAQs
1. What are the current statistics for the hereditary testing market?
2. What is the projected growth rate of the hereditary testing market?
3. Which region dominated the market share in 2024?
4. Who are the major players operating in the hereditary testing market?
5. Which technology segment held the largest market share in 2024?
6. How is hereditary testing defined?
7. What are the key trends shaping the hereditary testing market?
8. For new entrants, which strategic areas should be prioritized to gain a competitive edge in the hereditary testing market?
More Trending Reports by Polaris Market Research:
Rapid Oral Fluid Screening Devices Market:
https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid-screening-device-market
Neuralgia Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market
Actigraphy Sensors and PSG Devices Market:
https://www.polarismarketresearch.com/industry-analysis/actigraphy-sensors-psg-devices-market
Synoptophore Market:
https://www.polarismarketresearch.com/industry-analysis/synoptophore-market
Top Bioreactor Manufacturers in 2024: Simplifying Chemicals and Biological Reactions:
https://www.polarismarketresearch.com/blog/top-bioreactor-manufacturers
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Testing Market to Reach USD 17.13 billion by 2034, Driven by 8.3% CAGR Growth here
News-ID: 4009315 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
